Omalizumab retreatment in patients with chronic spontaneous urticaria: a systematic review of published evidence.

Anti-Allergic Agents / therapeutic use Chronic Urticaria / drug therapy Drug-Related Side Effects and Adverse Reactions Humans Omalizumab / therapeutic use Treatment Outcome
Chronic urticaria Omalizumab retreatment therapy

Journal

European annals of allergy and clinical immunology
ISSN: 1764-1489
Titre abrégé: Eur Ann Allergy Clin Immunol
Pays: Italy
ID NLM: 101466614

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 29 2 2020
medline: 29 6 2021
entrez: 29 2 2020
Statut: ppublish

Résumé

A systematic review of the current literature on retreatment with omalizumab of patients with relapsing chronic spontaneous urticaria was performed. Published evidence shows that retreatment is safe and clinically effective, and that time to complete clinical response reduces as the number of retreatments increases.

Identifiants

DOI: 10.23822/EurAnnACI.1764-1489.136 PMID: 32108461
pubmed: 32108461
doi: 10.23822/EurAnnACI.1764-1489.136
doi:

Substances chimiques

Anti-Allergic Agents 0
Omalizumab 2P471X1Z11

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100-103

Commentaires et corrections

Type : CommentIn

Auteurs

A Tonacci (A)

Institute of Clinical Physiology-National Research Council of Italy (IFC-CNR), Pisa, Italy.

E Nettis (E)

Department of Emergency and Organ Transplantation, School and Chair of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Italy.

R Asero (R)

Allergology Clinic, Clinica San Carlo, Paderno Dugnano, Milan, Italy.

O Rossi (O)

ImmunoAllergology Unit, Careggi University Hospital of Florence, Florence, Italy.

C Tontini (C)

Allergy Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.

S Gangemi (S)

School and Unit of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antiallergiques › Omalizumab retreatment in patients with...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie chronique › Urticaire chronique › Omalizumab retreatment in patients with...
questionsmedicales.fr › Troubles dus à des produits chimiques › Effets secondaires indésirables des médicaments › Omalizumab retreatment in patients with...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Omalizumab retreatment in patients with...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps monoclonaux › Anticorps monoclonaux humanisés › Omalizumab › Omalizumab retreatment in patients with...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Omalizumab retreatment in patients with...